| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| cis-trans-Isomerases | 20 | 2023 | 33 | 2.980 |
Why?
|
| Retinal Pigment Epithelium | 11 | 2024 | 25 | 2.170 |
Why?
|
| Eye Proteins | 18 | 2023 | 36 | 2.010 |
Why?
|
| Receptors, LDL | 5 | 2024 | 55 | 1.390 |
Why?
|
| Macular Degeneration | 4 | 2024 | 25 | 1.240 |
Why?
|
| Retina | 13 | 2023 | 83 | 1.230 |
Why?
|
| Fibrosis | 4 | 2024 | 126 | 1.140 |
Why?
|
| Carrier Proteins | 13 | 2011 | 148 | 1.080 |
Why?
|
| PPAR alpha | 8 | 2023 | 24 | 1.050 |
Why?
|
| MicroRNAs | 6 | 2023 | 181 | 0.960 |
Why?
|
| Mitochondria | 4 | 2024 | 207 | 0.950 |
Why?
|
| Animals | 46 | 2024 | 8165 | 0.940 |
Why?
|
| Mice | 29 | 2024 | 2544 | 0.930 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2024 | 6 | 0.850 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2024 | 9 | 0.850 |
Why?
|
| Retinal Degeneration | 6 | 2023 | 21 | 0.800 |
Why?
|
| Diabetic Retinopathy | 7 | 2018 | 71 | 0.750 |
Why?
|
| Pigment Epithelium of Eye | 6 | 2012 | 11 | 0.660 |
Why?
|
| Mice, Knockout | 15 | 2024 | 441 | 0.650 |
Why?
|
| Ischemia | 3 | 2022 | 115 | 0.560 |
Why?
|
| Mutagenesis, Site-Directed | 9 | 2014 | 64 | 0.540 |
Why?
|
| Hydrolases | 3 | 2008 | 5 | 0.530 |
Why?
|
| Zebrafish | 3 | 2012 | 23 | 0.530 |
Why?
|
| Vision, Ocular | 4 | 2022 | 33 | 0.480 |
Why?
|
| Retinal Pigments | 3 | 2005 | 6 | 0.480 |
Why?
|
| Retinal Cone Photoreceptor Cells | 4 | 2011 | 6 | 0.480 |
Why?
|
| Neovascularization, Pathologic | 2 | 2022 | 75 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 1 | 5 | 2023 | 267 | 0.470 |
Why?
|
| Amino Acid Sequence | 10 | 2012 | 293 | 0.440 |
Why?
|
| Molecular Sequence Data | 10 | 2012 | 368 | 0.440 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 87 | 0.420 |
Why?
|
| Mutation, Missense | 1 | 2014 | 47 | 0.420 |
Why?
|
| Cell Membrane | 3 | 2009 | 109 | 0.410 |
Why?
|
| Disease Models, Animal | 11 | 2023 | 1073 | 0.390 |
Why?
|
| Blotting, Western | 11 | 2017 | 297 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 776 | 0.380 |
Why?
|
| Alcohol Oxidoreductases | 2 | 2009 | 6 | 0.370 |
Why?
|
| Catalytic Domain | 1 | 2012 | 68 | 0.360 |
Why?
|
| Point Mutation | 3 | 2006 | 29 | 0.360 |
Why?
|
| Vitamin A | 7 | 2018 | 21 | 0.340 |
Why?
|
| Humans | 30 | 2024 | 32284 | 0.340 |
Why?
|
| Cells, Cultured | 11 | 2021 | 821 | 0.330 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2011 | 77 | 0.330 |
Why?
|
| Isotretinoin | 1 | 2011 | 13 | 0.330 |
Why?
|
| Cell Line | 6 | 2021 | 443 | 0.330 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2023 | 61 | 0.320 |
Why?
|
| Retinoids | 4 | 2021 | 42 | 0.310 |
Why?
|
| Palmitates | 2 | 2006 | 4 | 0.310 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 113 | 0.300 |
Why?
|
| Frizzled Receptors | 3 | 2021 | 5 | 0.300 |
Why?
|
| Glutamic Acid | 2 | 2009 | 50 | 0.300 |
Why?
|
| Palmitic Acid | 1 | 2008 | 9 | 0.290 |
Why?
|
| Retinal Diseases | 2 | 2022 | 25 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2020 | 1436 | 0.290 |
Why?
|
| Chickens | 4 | 2014 | 36 | 0.280 |
Why?
|
| Rod Opsins | 4 | 2006 | 4 | 0.250 |
Why?
|
| Cornea | 2 | 2023 | 16 | 0.240 |
Why?
|
| Diabetic Nephropathies | 3 | 2020 | 222 | 0.240 |
Why?
|
| Histidine | 1 | 2005 | 7 | 0.230 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2024 | 160 | 0.230 |
Why?
|
| Telomere | 1 | 2024 | 11 | 0.220 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2024 | 43 | 0.210 |
Why?
|
| Brain | 1 | 2011 | 966 | 0.210 |
Why?
|
| Retinal Rod Photoreceptor Cells | 4 | 2011 | 6 | 0.200 |
Why?
|
| Respiration | 1 | 2023 | 30 | 0.200 |
Why?
|
| Culture Media, Conditioned | 2 | 2021 | 50 | 0.200 |
Why?
|
| Energy Metabolism | 1 | 2024 | 150 | 0.190 |
Why?
|
| Kinetics | 4 | 2011 | 248 | 0.190 |
Why?
|
| Down-Regulation | 4 | 2017 | 131 | 0.180 |
Why?
|
| Genes, Dominant | 1 | 2022 | 27 | 0.180 |
Why?
|
| beta Catenin | 4 | 2016 | 38 | 0.180 |
Why?
|
| Amino Acid Substitution | 3 | 2014 | 40 | 0.180 |
Why?
|
| Cattle | 5 | 2014 | 118 | 0.180 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 9 | 0.180 |
Why?
|
| Photoreceptor Cells | 1 | 2001 | 4 | 0.170 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 16 | 0.170 |
Why?
|
| Ligands | 1 | 2021 | 90 | 0.160 |
Why?
|
| Smad2 Protein | 1 | 2020 | 5 | 0.160 |
Why?
|
| Smad3 Protein | 1 | 2020 | 8 | 0.160 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 23 | 0.160 |
Why?
|
| Kidney Tubules | 1 | 2020 | 25 | 0.160 |
Why?
|
| Mutation | 4 | 2023 | 497 | 0.160 |
Why?
|
| Rats | 6 | 2017 | 1892 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2011 | 83 | 0.140 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2018 | 1 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2020 | 716 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 2013 | 499 | 0.140 |
Why?
|
| Subcellular Fractions | 2 | 2008 | 15 | 0.130 |
Why?
|
| Retinal Neurons | 1 | 2017 | 4 | 0.130 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 544 | 0.130 |
Why?
|
| Rhodopsin | 1 | 2017 | 4 | 0.130 |
Why?
|
| Acyltransferases | 4 | 2011 | 18 | 0.130 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 254 | 0.130 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 172 | 0.130 |
Why?
|
| Species Specificity | 3 | 2014 | 98 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2017 | 100 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 104 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 293 | 0.120 |
Why?
|
| Capillary Permeability | 2 | 2013 | 17 | 0.120 |
Why?
|
| Protein Isoforms | 1 | 2016 | 60 | 0.120 |
Why?
|
| COS Cells | 4 | 2009 | 31 | 0.120 |
Why?
|
| Diabetes, Gestational | 1 | 2016 | 28 | 0.120 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 2005 | 18 | 0.120 |
Why?
|
| Tyrosine | 2 | 2013 | 24 | 0.110 |
Why?
|
| Recombinant Proteins | 5 | 2012 | 263 | 0.110 |
Why?
|
| Retinaldehyde | 4 | 2017 | 7 | 0.110 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2014 | 11 | 0.110 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 88 | 0.110 |
Why?
|
| Salamandridae | 3 | 2003 | 3 | 0.100 |
Why?
|
| Pericytes | 1 | 2014 | 31 | 0.100 |
Why?
|
| Kidney | 3 | 2016 | 520 | 0.100 |
Why?
|
| Retinal Vessels | 1 | 2014 | 25 | 0.100 |
Why?
|
| Models, Molecular | 2 | 2005 | 204 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2016 | 242 | 0.100 |
Why?
|
| Cloning, Molecular | 2 | 2011 | 77 | 0.100 |
Why?
|
| Antioxidants | 1 | 2014 | 119 | 0.100 |
Why?
|
| Receptors, Neuropeptide | 1 | 2013 | 4 | 0.100 |
Why?
|
| Apoptosis | 4 | 2017 | 367 | 0.090 |
Why?
|
| Genetic Vectors | 3 | 2009 | 109 | 0.090 |
Why?
|
| Phenylalanine | 1 | 2012 | 4 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 38 | 0.090 |
Why?
|
| Leucine | 1 | 2012 | 23 | 0.090 |
Why?
|
| Substrate Specificity | 1 | 2012 | 80 | 0.090 |
Why?
|
| Visual Pathways | 2 | 2017 | 42 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2017 | 246 | 0.090 |
Why?
|
| Oxidative Stress | 4 | 2014 | 241 | 0.090 |
Why?
|
| Vitamin A Deficiency | 1 | 2011 | 4 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 153 | 0.090 |
Why?
|
| Iron | 1 | 2011 | 93 | 0.080 |
Why?
|
| Pyridinium Compounds | 1 | 2010 | 5 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 246 | 0.080 |
Why?
|
| Evolution, Molecular | 3 | 2005 | 42 | 0.080 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 152 | 0.080 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2009 | 1 | 0.080 |
Why?
|
| Lipid Bilayers | 1 | 2009 | 5 | 0.070 |
Why?
|
| Phospholipids | 1 | 2009 | 32 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2008 | 40 | 0.070 |
Why?
|
| Adult | 4 | 2024 | 9263 | 0.070 |
Why?
|
| DNA, Complementary | 3 | 2005 | 30 | 0.070 |
Why?
|
| Phylogeny | 3 | 2005 | 75 | 0.070 |
Why?
|
| Transfection | 3 | 2014 | 198 | 0.070 |
Why?
|
| Female | 6 | 2024 | 19954 | 0.060 |
Why?
|
| Gene Expression | 4 | 2011 | 345 | 0.060 |
Why?
|
| Alanine | 1 | 2006 | 30 | 0.060 |
Why?
|
| Inflammation | 2 | 2022 | 500 | 0.060 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 1 | 2006 | 1 | 0.060 |
Why?
|
| Half-Life | 1 | 2006 | 24 | 0.060 |
Why?
|
| Cytosol | 1 | 2006 | 22 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 1485 | 0.060 |
Why?
|
| Vertebrates | 1 | 2005 | 2 | 0.060 |
Why?
|
| Ferrous Compounds | 1 | 2005 | 6 | 0.060 |
Why?
|
| Male | 5 | 2024 | 19434 | 0.060 |
Why?
|
| Cysteine | 1 | 2006 | 145 | 0.060 |
Why?
|
| Xenopus laevis | 1 | 2005 | 4 | 0.060 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 48 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 82 | 0.060 |
Why?
|
| Catalysis | 1 | 2005 | 71 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2018 | 49 | 0.060 |
Why?
|
| Base Sequence | 2 | 2003 | 256 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 122 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2002 | 40 | 0.050 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2017 | 7 | 0.050 |
Why?
|
| High-Throughput Screening Assays | 1 | 2024 | 13 | 0.050 |
Why?
|
| Middle Aged | 3 | 2024 | 11843 | 0.050 |
Why?
|
| Wnt Proteins | 2 | 2016 | 17 | 0.050 |
Why?
|
| Diterpenes | 2 | 2018 | 22 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2016 | 39 | 0.050 |
Why?
|
| Spectrophotometry | 1 | 2003 | 22 | 0.050 |
Why?
|
| Protein Binding | 2 | 2016 | 243 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 69 | 0.050 |
Why?
|
| Binding Sites | 1 | 2003 | 143 | 0.050 |
Why?
|
| Electroretinography | 1 | 2023 | 6 | 0.050 |
Why?
|
| Epithelium | 1 | 2023 | 24 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2022 | 8 | 0.050 |
Why?
|
| Diabetic Angiopathies | 1 | 2023 | 149 | 0.050 |
Why?
|
| DNA, Mitochondrial | 1 | 2022 | 32 | 0.050 |
Why?
|
| Biopsy | 1 | 2023 | 249 | 0.050 |
Why?
|
| Rats, Inbred BN | 2 | 2012 | 31 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2002 | 47 | 0.040 |
Why?
|
| Smad Proteins | 1 | 2021 | 7 | 0.040 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2021 | 7 | 0.040 |
Why?
|
| DNA | 1 | 2003 | 222 | 0.040 |
Why?
|
| Wound Healing | 1 | 2023 | 180 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 60 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2022 | 243 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2023 | 858 | 0.040 |
Why?
|
| Tissue Distribution | 2 | 2016 | 64 | 0.040 |
Why?
|
| Chromatography, Affinity | 2 | 2009 | 15 | 0.040 |
Why?
|
| Rana catesbeiana | 1 | 1999 | 1 | 0.040 |
Why?
|
| Amphibian Proteins | 1 | 1999 | 1 | 0.040 |
Why?
|
| Cyclin A1 | 1 | 2018 | 1 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2018 | 14 | 0.040 |
Why?
|
| Blindness | 2 | 2009 | 13 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 165 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2009 | 11 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 199 | 0.030 |
Why?
|
| Retinol-Binding Proteins, Plasma | 1 | 2017 | 3 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 111 | 0.030 |
Why?
|
| Retinal Neovascularization | 1 | 2017 | 6 | 0.030 |
Why?
|
| Microsomes | 2 | 2008 | 12 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 255 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 15 | 0.030 |
Why?
|
| Trophoblasts | 1 | 2016 | 8 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 599 | 0.030 |
Why?
|
| Placenta | 1 | 2016 | 74 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 1159 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 3938 | 0.030 |
Why?
|
| Protein Conformation | 2 | 2009 | 110 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 896 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 325 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2014 | 25 | 0.030 |
Why?
|
| Capillaries | 1 | 2014 | 25 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2014 | 12 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 43 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 24 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 110 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2014 | 83 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2014 | 248 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 151 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2014 | 137 | 0.030 |
Why?
|
| Trypsin | 1 | 2013 | 10 | 0.030 |
Why?
|
| Oxygen | 1 | 2014 | 134 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 122 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 963 | 0.020 |
Why?
|
| Leukostasis | 1 | 2012 | 3 | 0.020 |
Why?
|
| Glucose | 1 | 2013 | 158 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2012 | 41 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2012 | 85 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 478 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 15 | 0.020 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2011 | 1 | 0.020 |
Why?
|
| Opsins | 1 | 2011 | 2 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2011 | 45 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 50 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 102 | 0.020 |
Why?
|
| Tretinoin | 1 | 2011 | 33 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 190 | 0.020 |
Why?
|
| Fluorescence | 1 | 2010 | 22 | 0.020 |
Why?
|
| Static Electricity | 1 | 2009 | 13 | 0.020 |
Why?
|
| Phenotype | 1 | 2011 | 619 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 2652 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2009 | 54 | 0.020 |
Why?
|
| Liposomes | 1 | 2009 | 35 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 851 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 18 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 58 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 133 | 0.020 |
Why?
|
| Protein Transport | 1 | 2006 | 80 | 0.010 |
Why?
|
| Transducin | 1 | 2006 | 1 | 0.010 |
Why?
|
| Dark Adaptation | 1 | 2006 | 3 | 0.010 |
Why?
|
| Schiff Bases | 1 | 2005 | 3 | 0.010 |
Why?
|
| Isomerism | 1 | 2005 | 6 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2005 | 16 | 0.010 |
Why?
|
| Aged | 1 | 2018 | 10257 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2005 | 57 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2006 | 66 | 0.010 |
Why?
|
| Models, Biological | 1 | 2005 | 403 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 68 | 0.010 |
Why?
|